Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2015 April;150(2) > Giornale Italiano di Dermatologia e Venereologia 2015 April;150(2):255-60

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

REVIEWS   

Giornale Italiano di Dermatologia e Venereologia 2015 April;150(2):255-60

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Toll-like receptors pathways implication in common autoimmune diseases and therapeutic perspectives

Alexoudi I. 1, Kapsimali V. 2, Vaiopoulos A. 1, Kanakis M. 3, Vaiopoulos G. 1

1 Laikon Hospital, Athens, Greece; 2 Microbiological Department, Medical School University of Athens, Athens, Greece; 3 Onassis Cardiac Centre Athens, Athens, Greece


PDF


Toll-like receptors (TLRs) are a category of receptors that recognize and activate their signaling pathways to defend against the pathogen factors. However, an alteration in the proper activation might occurr, resulting in the production of proinflammatory cytokines. This improper activation is the beginning of an autoimmune disease. The inhibition of the implicated receptors or their pathways may prevent the induction of autoimmunity. This paper describes in detail new therapeutic opportunities based on the alteration of the TLR activation for rheumatoid arthritis and systemic lupus erythematosus.

top of page